Cargando…

Aminolaevulinic acid-induced photodynamic therapy: cellular responses to glucose starvation

Photodynamic therapy is a cancer treatment based on the interaction of light, oxygen and a photosensitiser. Protoporphyrin. IX is an endogenous photosensitiser derived from the pro-drug aminolaevulinic acid. Tumours contain areas of hypoxia and hypoglycaemia. Tumour cells adapt to these conditions b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wyld, L, Tomlinson, M, Reed, M W R, Brown, N J
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2002
Materias:	Experimental Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375344/ https://www.ncbi.nlm.nih.gov/pubmed/11953896 http://dx.doi.org/10.1038/sj.bjc.6600234

Ejemplares similares

Effects of light fractionation and different fluence rates on photodynamic therapy with 5-aminolaevulinic acid in vivo
por: Babilas, P, et al.
Publicado: (2003)

Enhanced effects of aminolaevulinic acid-based photodynamic therapy through local hyperthermia in rat tumours
por: Kelleher, D K, et al.
Publicado: (2003)

The role of reperfusion injury in photodynamic therapy with 5-aminolaevulinic acid – a study on normal rat colon
por: Curnow, A, et al.
Publicado: (2002)

The influence of hypoxia and pH on aminolaevulinic acid-induced photodynamic therapy in bladder cancer cells in vitro.
por: Wyld, L., et al.
Publicado: (1998)

Cell cycle phase influences tumour cell sensitivity to aminolaevulinic acid-induced photodynamic therapy in vitro.
por: Wyld, L., et al.
Publicado: (1998)

Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells
por: Sinha, A K, et al.
Publicado: (2006)

Porphyrin accumulation induced by 5-aminolaevulinic acid esters in tumour cells growing in vitro and in vivo
por: Tunstall, R G, et al.
Publicado: (2002)

Factors affecting aminolaevulinic acid-induced generation of protoporphyrin IX.
por: Wyld, L., et al.
Publicado: (1997)

The effect of aminolaevulinic acid-induced, protoporphyrin IX-mediated photodynamic therapy on the cremaster muscle microcirculation in vivo.
por: Leveckis, J., et al.
Publicado: (1995)

Efficacy of intravenous delta-aminolaevulinic acid photodynamic therapy on rabbit papillomas.
por: Lofgren, L. A., et al.
Publicado: (1995)

Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy.
por: Loh, C. S., et al.
Publicado: (1993)

Protoporphyrin IX enhancement by 5-aminolaevulinic acid peptide derivatives and the effect of RNA silencing on intracellular metabolism
por: Bourré, L, et al.
Publicado: (2009)

Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer.
por: Cairnduff, F., et al.
Publicado: (1994)

5-Aminolaevulinic Acid-Based Photodynamic Therapy Restrains Pathological Hyperplasia of Fibroblasts
por: Wang, Xiaochuan, et al.
Publicado: (2017)

Photodynamic therapy effect of m-THPC (Foscan®) in vivo: correlation with pharmacokinetics
por: Jones, H J, et al.
Publicado: (2003)

Role of cytokines in photodynamic therapy-induced local and systemic inflammation
por: Gollnick, S O, et al.
Publicado: (2003)

Ischaemia-reperfusion injury in photodynamic therapy-treated mouse tumours
por: Korbelik, M, et al.
Publicado: (2003)

5-aminolaevulinic acid-based photodynamic therapy inhibits ultraviolet B-induced skin photodamage
por: Hua, Hui, et al.
Publicado: (2019)

Photodynamic therapy on the normal rabbit larynx with phthalocyanine and 5-aminolaevulinic acid induced protoporphyrin IX photosensitisation.
por: Kleemann, D., et al.
Publicado: (1996)

In vitro studies on the potential use of 5-aminolaevulinic acid-mediated photodynamic therapy for gynaecological tumours.
por: Rossi, F. M., et al.
Publicado: (1996)

Methyl Aminolaevulinic Acid versus Aminolaevulinic Acid Photodynamic Therapy of Actinic Keratosis with Low Doses of Red-Light LED Illumination: Results of Long-Term Follow-Up
por: Fernández Guarino, Montserrat, et al.
Publicado: (2022)

Bax is essential for mitochondrion-mediated apoptosis but not for cell death caused by photodynamic therapy
por: Chiu, S-M, et al.
Publicado: (2003)

Photodynamic therapy using 5-aminolaevulinic acid for experimental pancreatic cancer--prolonged animal survival.
por: Regula, J., et al.
Publicado: (1994)

Dermoscopic Monitoring for Treatment and Follow-Up of Actinic Keratosis With 5-Aminolaevulinic Acid Photodynamic Therapy
por: Xiaoqin, Yang, et al.
Publicado: (2018)

Photodynamic detection of a feline meningioma using 5-aminolaevulinic acid hydrochloride
por: Osaki, Tomohiro, et al.
Publicado: (2020)

Combined hyperthermia and chlorophyll-based photodynamic therapy: tumour growth and metabolic microenvironment
por: Kelleher, D K, et al.
Publicado: (2003)

Porphyrin synthesis from ALA derivatives for photodynamic therapy. In vitro and in vivo studies
por: Perotti, C, et al.
Publicado: (2004)

Differentiation-dependent photodynamic therapy regulated by porphobilinogen deaminase in B16 melanoma
por: Ickowicz Schwartz, D, et al.
Publicado: (2004)

Differentiation enhances aminolevulinic acid-dependent photodynamic treatment of LNCaP prostate cancer cells
por: Ortel, B, et al.
Publicado: (2002)

Improving in vitro photodynamic therapy through the development of a novel iron chelating aminolaevulinic acid prodrug
por: Curnow, Alison, et al.
Publicado: (2019)

δ-Aminolaevulinic acid-induced photodynamic therapy inhibits protoporphyrin IX biosynthesis and reduces subsequent treatment efficacy in vitro
por: Gibson, S L, et al.
Publicado: (1999)

Recurrent growth factor starvation promotes drug resistance in human leukaemic cells
por: Saeki, K, et al.
Publicado: (2002)

Selective accumulation of ALA-induced PpIX and photodynamic effect in chemically induced hepatocellular carcinoma
por: Otake, M, et al.
Publicado: (2003)

Enhancement of 5-aminolaevulinic acid-induced photodynamic therapy in normal rat colon using hydroxypyridinone iron-chelating agents.
por: Curnow, A., et al.
Publicado: (1998)

Photodynamic therapy of normal rat arteries after photosensitisation using disulphonated aluminium phthalocyanine and 5-aminolaevulinic acid.
por: Grant, W. E., et al.
Publicado: (1994)

Foscan® uptake and tissue distribution in relation to photodynamic efficacy
por: Cramers, P, et al.
Publicado: (2003)

Selectivity of the photosensitiser Tookad® for photodynamic therapy evaluated in the Syrian golden hamster cheek pouch tumour model
por: Borle, F, et al.
Publicado: (2003)

Pegylation of charged polymer-photosensitiser conjugates: effects on photodynamic efficacy
por: Hamblin, M R, et al.
Publicado: (2003)

Differential cell death response to photodynamic therapy is dependent on dose and cell type
por: Wyld, L, et al.
Publicado: (2001)

Photodynamic therapy using intravenous delta-aminolaevulinic acid-induced protoporphyrin IX sensitisation in experimental hepatic tumours in rats.
por: Svanberg, K., et al.
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_p0pr2s4r41dcchfspgoqi3maar